Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...
More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results